UK weight loss supplements ads deemed misleading
A weight management food supplement claiming fat-binding powers has
been told to alter its marketing strategy by the UK advertising
watchdog.
Advertising Standards
Authority (ASA), which self-regulates the UK advertising industry,
upheld seven complaints lodged against supplements manufacturer Goldshield Healthcare Direct over advertising for a product called LIPObind.
The supplement contained French supplier, Bio Serae's Neopuntia weight loss cactus extract, and had been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK as a medical device.
It also met the requirements of the European Medical Devices Directive.
Resources: http://www.nutraingredients.com/news/ng.asp?n=85200-bio-serae-goldshield-healthcare-direct-mhra-neopuntia-weight-management
The supplement contained French supplier, Bio Serae's Neopuntia weight loss cactus extract, and had been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK as a medical device.
It also met the requirements of the European Medical Devices Directive.
Resources: http://www.nutraingredients.com/news/ng.asp?n=85200-bio-serae-goldshield-healthcare-direct-mhra-neopuntia-weight-management
» Leave a comment
- Your E-mail address is never displayed. If you enter it, it will only be visible to the blog author
- The line and paragraph breaks automatically
